Becton Dickinson Sees High Single-Digit Profit Growth Ahead, Plans Share Buybacks From Waters Deal
1. BDX beat Q4 earnings estimate of $3.92 with $3.96 per share. 2. Sales reached $5.89 billion, slightly below expectations. 3. Medical segment saw 11.2% growth, primarily in Vascular Access Management. 4. China's market procurement lowered revenues by ~100 basis points. 5. CFO exit announced; dividend increased by 1%, now $1.05 per share.